iBloC: a ground-breaking translational bladder cancer-on-chip model to empower development of novel immuno-oncology drugs

Forschungsstelle

INNOSUISSE

Projektnummer

104.320 IP-LS

Projekttitel

iBloC: a ground-breaking translational bladder cancer-on-chip model to empower development of novel immuno-oncology drugs

Projekttitel Englisch

iBloC: a ground-breaking translational bladder cancer-on-chip model to empower development of novel immuno-oncology drugs

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Biotechnology and processing
Abstract (Englisch)	The consortium will develop iBloC ? a novel drug screening platform that will accelerate and improve drug development for bladder cancer therapies. Here, we will deliver the first iBloC kit tailored to bladder cancer research, which will be ready to enter the market in Q1 2025.